Immunotherapy and Targeted Therapies in NSCLC: Phase 3 Data From ESMO 2022 - Cancer Therapy Advisor
Prof.Dr. Özcan YILDIZ | Doktorlarımız | Medipol Sağlık Grubu
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - ScienceDirect
Mustafa Özgüroğlu Özel Muayenehanesi, Şişli / İstanbul | Hekimler.Net
Akademik | Prof.Dr.Gökhan Demir
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-contr
Cancers | Free Full-Text | Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label,
Cancers | Free Full-Text | Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label,
Mustafa Ozguroglu - AI Profile | 人才画像- AMiner
BİRİNCİ BASAMAKTA ÖKSÜRÜK ŞİKAYETİ OLAN HASTAYA YAKLAŞIM - ppt video online indir
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile
İstanbul Üniversitesi - Cerrahpaşa | Hasan Ali Yücel Eğitim Fakültesi Pedagojik Formasyon Sertifika Programları
KANSER KEMOTERAPİSİ UYGULAMA İLKELERİ, Fuat H. Demirelli Mustafa Özgüroğlu Gökh - İkinci El Kitap - kitantik | #4522107000297
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - Lung Cancer
Jinekolojik Kanserlerde Tedavi | Nadir Kitap
Prof.Dr. MUSTAFA ÖZGÜROĞLU | AVESİS
Title of the study: Phase II Clinical Study Evaluating the Efficacy and Safety of Weekly Docetaxel and Four Weekly Carboplat
